Year: 2020

Cenovus reaches agreement to accelerate development of its Marten Hills oil assets

Written by Customer Service on November 9, 2020. Posted in Public Companies.

CALGARY, Alberta, Nov. 09, 2020 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE), through a wholly owned partnership, has entered into a definitive agreement to sell its Marten Hills oil assets in northern Alberta to Headwater Exploration Inc. for initial cash and common share equity consideration of approximately $100 million.Total consideration paid to Cenovus consists of $35 million in cash and 50 million common shares of Headwater, plus 15 million share purchase warrants. Each warrant will entitle the holder to acquire one Headwater common share for a period of three years following the completion of the transaction at an exercise price of $2 per share. Upon closing, Kam Sandhar, Senior Vice-President, Conventional and Sarah Walters, Senior Vice-President, Corporate Services will represent Cenovus on the Board of...

Base Station Antenna Market to Hit $18.37 Billion by 2027; Surging Number of Smartphone Users Worldwide to Rapidly Expand Market Horizons: Fortune Business Insights™

Written by Customer Service on November 9, 2020. Posted in Mergers And Acquisitions.

Pune, Nov. 09, 2020 (GLOBE NEWSWIRE) — The global base station antenna market size is projected to reach USD 18.37 billion by 2027, exhibiting a CAGR of 16.2% during the forecast period. The gradual rollout of 5G infrastructures around the world will be the most crucial growth determinant for this market, observes Fortune Business Insights™ in its report, titled “Base Station Antenna Market Size, Share & COVID-19 Impact Analysis, By Type (Omni Antenna, Sector Antenna, Dipole Antenna, Multibeam Antenna, Small Cell, and Others), By Technology (3G, 4G/LTE, and 5G), By Application (Mobile Communication, Intelligent Transport, Industrial IoT, Smart City, Military and Defense and Others), and Regional Forecast, 2020-2027”.Click here to get the short-term and long-term impact of COVID-19 on this Market.Please visit: https://www.fortunebusinessinsights.com/base-station-antennas-market-103525According...

Great Elm Capital Corp. Declares Quarterly Cash Distribution of $0.10 per Share

Written by Customer Service on November 9, 2020. Posted in Dividend Reports And Estimates.

WALTHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (“we,” “us,” “our,” “GECC,” or “Great Elm BDC”), (NASDAQ: GECC), a business development company (BDC), today announced that Great Elm BDC’s Board set the distribution for the quarter ending March 31, 2021 at $0.10 per quarter.The distributions will be paid in cash and covered by net investment income. The record and payment dates for the distribution are expected to be set by GECC in December pursuant to authority granted by the Board.Peter A. Reed, GECC’s Chief Executive Officer, stated, “We were pleased to increase the cash portion of our distribution while maintaining a favorable overall return to shareholders following the completion of our rights offering. On an annualized basis, this currently represents a 9.6% yield on NAV (based on Net Asset Value of...

Mitek to Participate in the Benchmark Company Technology Virtual 1×1 Investor Conference on November 12, 2020

Written by Customer Service on November 9, 2020. Posted in Public Companies.

SAN DIEGO, Nov. 09, 2020 (GLOBE NEWSWIRE) — Mitek (NASDAQ: MITK), a global leader in mobile capture and digital identity verification solutions, today announced it has been invited to participate at the Benchmark Company Technology Virtual 1×1 Investor Conference on November 12, 2020.Mitek’s CEO Max Carnecchia, and CFO Jeff Davison will hold virtual meetings with institutional investors throughout the day.For additional information or to schedule a one-on-one meeting with Mitek, please contact your Benchmark representative, or MKR Investor Relations, Mitek’s investor relations firm, at mitk@mkr-group.com.About MitekMitek (NASDAQ: MITK) is a global leader in mobile capture and digital identity verification built on the latest advancements in computer vision and artificial intelligence. Mitek’s identity verification solutions...

COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care

Written by Customer Service on November 9, 2020. Posted in Public Companies.

London, UK – 9 November 2020COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has joined the Psychiatry Consortium, an international collaboration to accelerate drug discovery and development in areas of urgent, unmet medical need.The Psychiatry Consortium, managed by Medicines Discovery Catapult, is a strategic collaboration of leading medical research charities and pharmaceutical companies focusing on the challenge of identifying and validating novel drug targets to address the unmet therapeutic needs of people living with mental health conditions. COMPASS Pathways will work alongside Psychiatry Consortium members and academic partners to advance research projects, providing support through access to funding, expertise, and...

Codexis to Participate at Three Virtual Investment Conferences in November

Written by Customer Service on November 9, 2020. Posted in Public Companies.

REDWOOD CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate at three upcoming virtual investment conferences:Stifel Healthcare Conference on Monday, November 16, 2020 with presentation at 3:20 p.m. Eastern time (12:20 p.m. Pacific time) 11thAnnual Craig-Hallum Alpha Select Conference on Tuesday, November 17, 2020 Stephens Annual Investment Conference 2020 on Wednesday, November 18, 2020 with presentation at 1:00 p.m. Eastern time (10:00 a.m. Pacific time)Live webcasts and replays of the presentations at the Stifel Healthcare Conference and Stephens Annual Investment Conference will be available on the Investors section of the company’s website, http://ir.codexis.com/.About Codexis, Inc.Codexis is a leading protein engineering...

Morphic Announces Corporate Highlights and Third Quarter 2020 Financial Results

Written by Customer Service on November 9, 2020. Posted in Public Companies.

Initiated phase 1 clinical trial for MORF-057 with results expected by mid-2021Presented data at UEG 2020 that reinforce preclinical potency and selectivity profile of MORF-057Received $20 million from AbbVie exercising option to αvβ6 integrin inhibitor programWALTHAM, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today reported corporate highlights and third quarter 2020 financial results.“During the third quarter, Morphic made the most noteworthy progress yet in our mission to deliver the first generation of oral medicines targeting integrin receptors. In September, we announced that the first healthy volunteers received MORF-057 in a phase 1 clinical trial designed to...

Calithera Biosciences Presents New Preclinical Data for CB-668 at Society for Immunotherapy of Cancer (SITC) 2020 Annual Meeting

Written by Customer Service on November 9, 2020. Posted in Public Companies.

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, announced that new preclinical data for the company’s novel IL4I1 inhibitor CB-668 will be presented at the Society for Immunotherapy of Cancer (SITC) Virtual Annual Meeting 2020.CB-668 is a potent, selective, small-molecule, oral inhibitor of IL4I1, an amino acid oxidase that inhibits anti-tumor immunity and promotes tumor growth. IL4I1 regulates several aspects of adaptive immunity, including inhibition of cytotoxic T cells through its production of both hydrogen peroxide and activators of the aryl hydrocarbon receptor. CB-668 increases pro-inflammatory gene...

PV Nano Cell Awarded Patent in Brazil

Written by Customer Service on November 9, 2020. Posted in Public Companies.

MIGDAL HA’EMEK, Israel, Nov. 09, 2020 (GLOBE NEWSWIRE) — PV Nano Cell, Ltd. (OTCQB: PVNNF) (“PV Nano Cell” or the “Company”), an innovative provider of inkjet-based conductive digital printing solutions and producer of conductive digital inks, today announced that it has been granted a patent in Brazil, BR 11 2013 013885-8 A2, Method to Produce Concentrated Dispersions of Nanometric Particles of Silver. The allowance was published in the Brazilian Industrial Property Gazette no. 2596 in October.This patent is part of the company’s special nano silver family of patents protecting its products and technologies. PV Nano Cell is leveraging its technologies and products development to provide a complete solution enabling customers to fully realize the potential of inkjet based electronics printing for mass...

Emerging Markets Report: In Good Company

Written by Customer Service on November 9, 2020. Posted in Public Companies.

ORLANDO, Fla., Nov. 09, 2020 (GLOBE NEWSWIRE) — Kisses From Italy, Inc. (OTCQB:KITL) is about to embark on a journey to rapidly expand its brand and offerings. News from last week makes this clear. Let’s take a look at the significance of the news the Company has entered into an agreement with All Points Public Relations to take the lead on brand PR support, franchise development advertising and digital marketing initiatives aimed at driving franchise lead generation for Kisses from Italy’s franchising program.It’s a significant event for followers of the Italian food maker and restaurant chain. First, it signals internal confidence that the Company is both positioned and poised for growth. Frankly put, you don’t onboard the expense of a firm like All Points Public Relations if you don’t have a story to tell.Conversely, we...

Year: 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals